Vienna-based Flinn.ai has secured $20 million in a Series A round led by HV Capital to automate regulatory and quality compliance for medical device and pharmaceutical companies. The funding will fuel its expansion into the US market and extend its AI platform across the entire product lifecycle.
Canadian transcription firm VIQ Solutions has admitted to a significant data breach after subcontracting work to an Indian firm, e24 Technologies, exposing highly sensitive Australian federal and state court files. The incident, raises major national security concerns
Hand coded robotics is fading as Figure AI replaces C++ with neural networks running pixels to torque control. Brett Adcock’s bet on Hark reframes humanoids as infrastructure, where robot fleets learn collectively and the real value shifts to the model layer powering physical autonomy.
Vienna-based Flinn.ai has secured $20 million in a Series A round led by HV Capital to automate regulatory and quality compliance for medical device and pharmaceutical companies. The funding will fuel its expansion into the US market and extend its AI platform across the entire product lifecycle.
Cyber News Centre's AI startup update for 25th February 2026: Flinn.ai, a Vienna-based company developing an AI platform for medical device and pharmaceutical compliance, has secured $20 million in a Series A funding round.
Flinn.ai provides an AI-driven platform that automates quality and regulatory processes for manufacturers in the MedTech and pharmaceutical sectors. The software streamlines the entire product lifecycle, from R&D to post-market surveillance, helping companies navigate complex compliance frameworks like Europe's MDR and IVDR.
Update: Vienna-based Flinn.ai has secured $20 million in a Series A funding round led by HV Capital, with participation from US healthcare investor BHI – Bertelsmann Healthcare Investments, and existing backers Cherry Ventures, Speedinvest, and SquareOne.
The investment will be used to expand the company's AI platform across the entire medical product lifecycle, from research and development to commercial processes, and to support its entry into the US market. Flinn.ai's software automates workflows for post-market surveillance, literature evaluation, and complaint handling, replacing manual, document-heavy processes. The company counts Carl Zeiss, Philips, and Paul Hartmann among its clients.
"Our software is designed to replace manual, document-heavy workflows with automated systems that scale across products, markets, and regulatory regimes," said Bastian Krapinger-Rüther, Co-Founder and Co-CEO of Flinn.ai.
The new funding brings the company's total raised to approximately $30 million.
Why it Matters: The funding addresses a significant pain point in the multi-billion dollar medical device industry: the high cost and complexity of regulatory compliance. Adhering to standards like Europe's Medical Device Regulation (MDR) can cost manufacturers tens of thousands of dollars per product certification, creating a substantial barrier to innovation.
By automating these processes, Flinn.ai's platform can reduce administrative overhead, shorten development timelines, and lower the risk of non-compliance. This allows MedTech and pharmaceutical companies to allocate resources more effectively towards innovation and product development, ultimately accelerating the delivery of new healthcare solutions to market.
Get the stories that matter to you.
Subscribe to Cyber News Centre and update your preferences to follow our Daily 4min Cyber Update, Innovative AI Startups, The AI Diplomat series, or the main Cyber News Centre newsletter — featuring in-depth analysis on major cyber incidents, tech breakthroughs, global policy, and AI developments.
Render secures $100M Series C extension , hitting $1.5B valuation & $258M total funding. Led by Georgian with Addition, Bessemer, GC. Building unified AI cloud platform with Workflows, AI gateway & object storage for agentic apps—a key developer-friendly alternative to hyperscalers
Artificial Labs has raised $45M in Series B funding to expand its AI-driven underwriting platform across global insurance markets. Backed by CommerzVentures, the London insurtech aims to modernise specialty insurance through automation, data intelligence, and scalable digital trading.
San Francisco-based AI startup Fieldguide has closed a $75 million Series C funding round led by Goldman Sachs Alternatives' growth equity group, achieving a $700 million post-money valuation. The raise brings total venture funding to $125 million as the firm expands its AI enterprise platform.
Israeli startup Factify has raised $73 million in a seed round to build a new document standard for the AI era, aiming to replace the static PDF with intelligent, governable records. The funding was led by Valley Capital Partners and backed by prominent figures in technology and finance.
Where cybersecurity meets innovation, the CNC team delivers AI and tech breakthroughs for our digital future. We analyze incidents, data, and insights to keep you informed, secure, and ahead. Sign up for free!
